Discontinued — last reported Q4 '20
Business Segments · Segment revenues
Covance Drug Development — Segment revenues
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2018
Last reportedQ4 2020
How to read this metric
Growth indicates successful market penetration and demand for research services, while a decline signals potential loss of market share or reduced R&D spending by clients.
Detailed definition
The total gross revenue generated by the drug development business segment from external customers. This metric measures...
Peer comparison
Standard revenue reporting across all public companies with segmented business models.
Metric ID:
lh_segment_covance_drug_development_segment_revenuesSimilar Metrics at Other Companies
Frequently Asked Questions
- What does covance drug development — segment revenues mean?
- Total sales generated by the drug development business unit.